Abstract
Liver tumors in pediatric patients present a unique clinical challenge. They are relatively rare, with an incidence of 0.7 per million population. However, two-thirds of primary liver tumors are malignant. They commonly present with nonspecific symptoms until presenting definitively at an advanced stage, with a mass in the right-upper quadrant or epigastrium. Some infantile tumors lack invasive potential, yet they remain life-threatening due to a diffuse nature that may cause high-output cardiac failure, compression of adjacent structures, or risk of malignant degeneration. A normally functioning liver is critical for childhood development, and some tumors are particularly aggressive, disrupting normal physiology and growth. The incidence of liver tumors in Western countries has increased, partially as a result of improved detection via noninvasive imaging. Several tumor types can arise in the setting of viral hepatitis or metabolic liver disease; however, many arise from normal liver parenchyma without any known environmental or genetic risk factors.
The two most common hepatic malignancies in pediatric and adolescent patients are hepatoblastoma and hepatocellular carcinoma. Hepatoblastoma arises in infants and young children, while hepatocellular carcinoma arises in older children. Advances in chemotherapy have greatly improved the outcomes of hepatoblastoma; however, these gains have not proven effective in hepatocellular carcinoma. The most common benign liver tumors are hemangioendothelioma, mesenchymal hamartoma, and focal nodular hyperplasia. Serial imaging, embolization, chemotherapy, surgical resection, and transplantation have been used in the treatment of benign and malignant tumors of the liver. Most data have consistently shown improved overall survival with complete resection, aided by early detection, neoadjuvant therapy, and improved perioperative care. Further improvements will come from multi-institutional and multinational cooperative studies. With the low incidence of these tumors, cooperative groups are vital to collect samples for biologic and genomic analysis, in order to determine exposure risks, prognostic factors, and outcomes data.
References
Allan BJ, Wang B, Davis JS, Parikh PP, Perez EA, Neville HL, et al. A review of 218 pediatric cases of hepatocellular carcinoma. J Pediatr Surg. 2014;49(1):166–71.
Baron PW, Majlessipour F, Bedros AA, Zuppan CW, Ben-Youssef R, Yanni G, et al. Undifferentiated embryonal sarcoma of the liver successfully treated with chemotherapy and liver resection. J Gastrointest Surg. 2007;11(1):73–5.
Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B, Sa Cunha A, Rullier A, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50(2):481–9.
Bisogno G, Pilz T, Perilongo G, Ferrari A, Harms D, Ninfo V, et al. Undifferentiated sarcoma of the liver in childhood: a curable disease. Cancer. 2002;94(1):252–7.
Browne M, Sher D, Grant D, Deluca E, Alonso E, Whitington PF, et al. Survival after liver transplantation for hepatoblastoma: a 2-center experience. J Pediatr Surg. 2008;43(11):1973–81.
Calderaro J, Labrune P, Morcrette G, Rebouissou S, Franco D, Prevot S, et al. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. J Hepatol. 2013;58(2):350–7.
Christison-Lagay ER, Burrows PE, Alomari A, Dubois J, Kozakewich HP, Lane TS, et al. Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg. 2007;42(1):62–8.
Daller JA, Bueno J, Gutierrez J, Dvorchik I, Towbin RB, Dickman PS, et al. Hepatic hemangioendothelioma: clinical experience and management strategy. J Pediatr Surg. 1999;34(1):98–106.
Darbari A, Sabin KM, Shapiro CN, Schwarz KB. Epidemiology of primary hepatic malignancies in U.S children. Hepatology. 2003;38(3):560–6.
De Ioris M, Brugieres L, Zimmermann A, Keeling J, Brock P, Maibach R, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer. 2008;44(4):545–50.
Emre S, Umman V, Rodriguez-Davalos M. Current concepts in pediatric liver tumors. Pediatr Transplant. 2012;16(6):549–63.
Finegold MJ, Egler RA, Goss JA, Guillerman RP, Karpen SJ, Krishnamurthy R, et al. Liver tumors: pediatric population. Liver Transpl. 2008;14(11):1545–56.
Fukahori S, Tsuru T, Tanikawa K, Akiyoshi K, Asagiri K, Tanaka Y, et al. Mesenchymal hamartoma of the liver accompanied by a daughter nodule: report of a case. Surg Today. 2007;37(9):811–6.
Glick RD, Nadler EP, Blumgart LH, La Quaglia MP. Extended left hepatectomy (left hepatic trisegmentectomy) in childhood. J Pediatr Surg. 2000;35(2):303–8.
Hughes JA, Hill V, Patel K, Syed S, Harper J, De Bruyn R. Cutaneous haemangioma: prevalence and sonographic characteristics of associated hepatic haemangioma. Clin Radiol. 2004;59(3):273–80.
Honeyman and LaQuaglia. Malignant liver tumors. Semin Pediatr Surg. 2012;21:245–54.
Kochin IN, Miloh TA, Arnon R, Iyer KR, Suchy FJ, Kerkar N. Benign liver masses and lesions in children: 53 cases over 12 years. Isr Med Assoc J. 2011;13(9):542–7.
Kulungowski AM, Alomari AI, Chawla A, Christison-Lagay ER, Fishman SJ. Lessons from a liver hemangioma registry: subtype classification. J Pediatr Surg. 2012;47(1):165–70.
Lauferman L, Halac E, Aredes D, et al. Prognostic factors for event-free survival in liver transplantation for hepatoblastoma: a single-center experience. Pediatr Transplant. 2019;17:e13581.
Laumonier H, Bioulac-Sage P, Laurent C, Zucman-Rossi J, Balabaud C, Trillaud H. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 2008;48(3):808–18.
Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer. 2008;112(2):416–32.
Malek MM, Shah SR, Atri P, Paredes JL, DiCicco LA, Sindhi R, et al. Review of outcomes of primary liver cancers in children: our institutional experience with resection and transplantation. Surgery. 2010;148(4):778–84.
Malogolowkin MH, Katzenstein HM, Krailo M, Chen Z, Quinn JJ, Reynolds M, et al. Redefining the role of doxorubicin for the treatment of children with hepatoblastoma. J Clin Oncol. 2008;26(14):2379–83.
Malogolowkin MH, Katzenstein HM, Meyers RL, Krailo MD, Rowland JM, Haas J, et al. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the children’s oncology group. J Clin Oncol. 2011;29(24):3301–6.
Masetti R, Zama D, Gasperini P, Morello W, Prete A, Colecchia A, et al. Focal nodular hyperplasia of the liver in children after hematopoietic stem cell transplantation. Pediatr Transplant. 2013;17(5):479–86.
McAteer JP, Goldin AB, Healey PJ, Gow KW. Hepatocellular carcinoma in children: epidemiology and the impact of regional lymphadenectomy on surgical outcomes. J Pediatr Surg. 2013;48(11):2194–201.
Medary I, Aronson D, Cheung NK, Ghavimi F, Gerald W, La Quaglia MP. Kinetics of primary tumor regression with chemotherapy: implications for the timing of surgery. Ann Surg Oncol. 1996;3(6):521–5.
Meyers RL, Katzenstein HM, Krailo M, McGahren ED, Malogolowkin MH. Surgical resection of pulmonary metastatic lesions in children with hepatoblastoma. J Pediatr Surg. 2007;42(12):2050–6.
Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the children’s oncology group. Pediatr Blood Cancer. 2009;53(6):1016–22.
Mo JQ, Dimashkieh HH, Bove KE. GLUT1 endothelial reactivity distinguishes hepatic infantile hemangioma from congenital hepatic vascular malformation with associated capillary proliferation. Hum Pathol. 2004;35(2):200–9.
Ng K, Mogul DB. Pediatric liver tumors. Clin Liver Dis. 2018;22(4):753–72.
Ortega JA, Douglass EC, Feusner JH, Reynolds M, Quinn JJ, Finegold MJ, et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the children’s cancer group and the pediatric oncology group. J Clin Oncol. 2000;18(14):2665–75.
Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer. 2004;42(1):74–83.
Perilongo G, Maibach R, Shafford E, Brugieres L, Brock P, Morland B, et al. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med. 2009;361(17):1662–70.
Rahmat K, Vijayananthan A, Abdullah B, Amin S. Benign teratoma of the liver: a rare cause of cholangitis. Biomed Imaging Interv J. 2006;2(3):e20.
Ranganathan S, Lopez-Terrada D, Alaggio R. Hepatoblastoma and pediatric hepatocellular carcinoma: an update. Pediatr Dev Pathol. 2019;25:1093526619875228.
Ravindra KV, Cullinane C, Lewis IJ, Squire BR, Stringer MD. Long-term survival after spontaneous rupture of a malignant rhabdoid tumor of the liver. J Pediatr Surg. 2002;37(10):1488–90.
Rebouissou S, Bioulac-Sage P, Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008;48(1):163–70.
Roebuck DJ, Aronson D, Clapuyt P, Czauderna P, de Ville de Goyet J, Gauthier F, et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol. 2007;37(2):123–32, 249–50
Schnater JM, Aronson DC, Plaschkes J, Perilongo G, Brown J, Otte J-B, et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer. 2002;94(4):1111–20.
Stringer MD, Alizai NK. Mesenchymal hamartoma of the liver: a systematic review. J Pediatr Surg. 2005;40(11):1681–90.
Tajiri H, Tanaka H, Brooks S, Takano T. Reduction of hepatocellular carcinoma in childhood after introduction of selective vaccination against hepatitis B virus for infants born to HBV carrier mothers. Cancer Causes Control. 2010;22(3):523–7.
Towbin AJ, Meyers RL, Woodley H, et al. PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric hepatic international tumour trial (PHITT). Pediatr Radiol. 2018;48(4):536–54.
Towbin AJ, Luo GG, Yin H, Mo JQ. Focal nodular hyperplasia in children, adolescents, and young adults. Pediatr Radiol. 2011;41(3):341–9.
Trobaugh-Lotrario AD, Tomlinson GE, Finegold MJ, Gore L, Feusner JH. Small cell undifferentiated variant of hepatoblastoma: adverse clinical and molecular features similar to rhabdoid tumors. Pediatr Blood Cancer. 2009;52(3):328–34.
Trobaugh-Lotrario AD, Finegold MJ, Feusner JH. Rhabdoid tumors of the liver: rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy. Pediatr Blood Cancer. 2011;57(3):423–8.
Umeda K, Okajima H, Kawaguchi K, et al. Prognostic and therapeutic factors influencing the clinical outcome of hepatoblastoma after liver transplantation: a single-institute experience. Pediatr Transplant. 2018;22(2):e13113–e13160.
van Aalten SM, de Man RA, IJzermans JNM, Terkivatan T. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg. 2012;99(7):911–6.
von Schweinitz D. Neonatal liver tumours. Semin Neonatol. 2003;8(5):403–10.
von Schweinitz D. Management of liver tumors in childhood. Semin Pediatr Surg. 2006;15(1):17–24.
Weinberg AG, Finegold MJ. Primary hepatic tumors of childhood. Hum Pathol. 1983;14(6):512–37.
Wu JT, Book L, Sudar K. Serum alpha fetoprotein (AFP) levels in normal infants. Pediatr Res. 1981;15(1):50–2.
Yu S-B, Kim H-Y, Eo H, Won J-K, Jung S-E, Park K-W, et al. Clinical characteristics and prognosis of pediatric hepatocellular carcinoma. World J Surg. 2006;30(1):43–50.
Yuri T, Danbara N, Shikata N, Fujimoto S, Nakano T, Sakaida N, et al. Malignant rhabdoid tumor of the liver: case report and literature review. Pathol Int. 2004;54(8):623–9.
Zsíros J, Maibach R, Shafford E, Brugieres L, Brock P, Czauderna P, et al. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study. J Clin Oncol. 2010;28(15):2584–90.
Zsíros J, Brugieres L, Brock P, Roebuck D, Maibach R, Zimmermann A, et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol. 2013;14(9):834–42.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer-Verlag GmbH Germany, part of Springer Nature
About this entry
Cite this entry
Darcy, D.G., Honeyman, J.N., La Quaglia, M.P. (2020). Liver Tumors. In: Puri, P. (eds) Pediatric Surgery. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38482-0_148-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-38482-0_148-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-38482-0
Online ISBN: 978-3-642-38482-0
eBook Packages: Springer Reference MedicineReference Module Medicine